Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

"Daddy, what is erectile dysfunction?" Direct-to-consumer advertising will be changing.

Feinberg DT.

J Child Adolesc Psychopharmacol. 2005 Dec;15(6):866-8. No abstract available.

PMID:
16379506
2.

FDA considers tightening regulations for direct-to-consumer advertising.

Vastag B.

J Natl Cancer Inst. 2005 Dec 21;97(24):1806-7. No abstract available.

3.

The role of direct-to-consumer advertising.

Navarro RP.

Manag Care Interface. 1998 Nov;11(11):79-80, 82. No abstract available.

PMID:
10187419
4.

Reforming direct-to-consumer advertising.

Liang BA, Mackey T.

Nat Biotechnol. 2011 May;29(5):397-400. doi: 10.1038/nbt.1865. No abstract available.

PMID:
21552236
5.

Drug firms back-pedal on direct advertising.

[No authors listed]

Nature. 2005 Aug 18;436(7053):910-1. No abstract available.

PMID:
16107811
6.

Direct-to-Consumer advertising for prescription drugs.

Schommer JC.

Minn Med. 2005 Mar;88(3):32-3, 45. No abstract available.

PMID:
15852593
7.

Direct-to-consumer prescription drug advertising.

Bradley LR, Zito JM.

Med Care. 1997 Jan;35(1):86-92. No abstract available.

PMID:
8998206
8.

Direct-to-consumer prescription drug advertising.

Terzian TV.

Am J Law Med. 1999;25(1):149-67. Review. No abstract available.

PMID:
10207573
9.

US aims to tighten rules on direct-to-consumer drug ads.

Vastag B.

Nat Biotechnol. 2007 Mar;25(3):267. No abstract available.

PMID:
17344868
10.

Direct-to-consumer advertising of prescription medications: Do you see what the public sees?

Hampl JS, Bramlett-Solomon S, Wharton CM.

J Am Diet Assoc. 2006 Dec;106(12):1937-40, 1942-3, 1945-6. No abstract available.

PMID:
17126621
11.
12.

The new drug marketing: a consumer protection perspective.

Woodward D.

Food Drug Law J. 1996;51(4):637-50. No abstract available.

PMID:
11797733
13.

Direct-to-consumer advertising of drugs.

Weinmeyer R.

Virtual Mentor. 2013 Nov 1;15(11):954-8. doi: 10.1001/virtualmentor.2013.15.11.hlaw1-1311. No abstract available.

14.

Caveat doctor.

McCarthy M.

Lancet. 1999 Aug 7;354(9177):446. No abstract available.

PMID:
10465167
15.

Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.

Strawn MN.

J Contemp Health Law Policy. 2003 Spring;19(2):495-520. Review. No abstract available.

PMID:
14748255
16.

Direct-to-consumer advertising: for better profits or for better health?

Hoen E.

Am J Health Syst Pharm. 1998 Mar 15;55(6):594-7. No abstract available.

PMID:
9544337
17.

In Opposition to Liberty: We Need a "Sovereign" to Govern Drug Claims.

Avorn J.

Ann Intern Med. 2015 Aug 4;163(3):229-30. doi: 10.7326/M15-1429. No abstract available.

PMID:
26121615
18.

FDA investigates direct to consumer adverts.

Lenzer J.

BMJ. 2005 Nov 12;331(7525):1102. No abstract available.

19.

Europe on the brink of direct-to-consumer drug advertising.

[No authors listed]

Lancet. 2002 May 18;359(9319):1709. No abstract available.

PMID:
12049853
20.

To ban or not to ban--that is the question: the constitutionality of a moratorium on consumer drug advertising.

Schwartz MI.

Food Drug Law J. 2008;63(1):1-33. No abstract available.

PMID:
18561453
Items per page

Supplemental Content

Support Center